| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |